Inspiration Healthcare Group PLC (IHC) · 2026-10-27
Half-year Financial Report
Inspiration Healthcare upgraded its FY27 revenue expectation to at least £43.0 million after underlying H1 revenue rose 26%, but reported revenue fell to £22.0 million from £24.0 million as the prior period included £6.5 million of one-off export orders, and gross margin fell to 41.9% from 46.2%.
Inspiration Healthcare Group plc (IHC) · 2026-09-08
Trading update for six months ended 31 July 2026
Inspiration Healthcare expects to finish the financial year slightly ahead of market expectations despite H1 revenue falling to £22.0 million from £24.0 million, as the prior period included £6.5 million of one-off contracts. Underlying SLE neonatal intensive care product revenue grew 38% to £12.7 million.
Inspiration Healthcare Group plc (IHC) · 2026-07-23
AGM Statement
Inspiration Healthcare Group said FY26 revenue increased 24% to £47.5 million, gross profit rose 27% to £20.8 million and adjusted EBITDA improved to £2.8 million. The group also reported operating cash inflows of £7.5 million and a 39% reduction in net debt.
Inspiration Healthcare Group plc (IHC) · 2026-06-16
Final Results
Inspiration Healthcare reported FY26 revenue of £47.5m, up 24%, and returned to adjusted operating profit. It also generated £7.5m of operating cash inflow and said FY27 trading is in line with Board expectations.
Inspiration Healthcare Group plc (IHC) · 2026-06-02
Transfer of Non-Core Products to Focus on Neonatal
Inspiration Healthcare Group plc agreed to transfer the distribution of Micrel infusion products back to the manufacturer by 31 January 2027. The division generated £9.7m revenue in FY26. The board expects staff transfers and compensation payments to reduce net debt by approximately 20% during FY27.